Proteomics analysis of serum from patients with invasive ductal carcinoma
Ontology highlight
ABSTRACT: Mass spectrometry was utilized to analyze enriched, low abundance proteins from patient serum, in patients with invasive ductal carcinoma (IDC) breast cancer and controls with a positive mammogram and negative biospy. Proteins in each group were compared to identify IDC specific markers.
INSTRUMENT(S):
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Blood Plasma
DISEASE(S): Breast Cancer
SUBMITTER:
Krystine Mansfield
LAB HEAD: Emanuel Petricoin
PROVIDER: PXD020129 | Pride | 2021-09-09
REPOSITORIES: Pride
ACCESS DATA